Khanna, S., Thomas, A., Abate-Daga, D., Zhang, J., Morrow, B., Steinberg, S.m., et al. (2016). Malignant Mesothelioma Effusions Are Infiltrated by CD3+ T Cells Highly Expressing PD-L1 and the PD-L1+ Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti–PD-L1 Antibody Avelumab. JOURNAL OF THORACIC ONCOLOGY [10.1016/j.jtho.2016.07.033].

Malignant Mesothelioma Effusions Are Infiltrated by CD3+ T Cells Highly Expressing PD-L1 and the PD-L1+ Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti–PD-L1 Antibody Avelumab

ORLANDI, AUGUSTO;
2016-08

Online ahead of print
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/06 - Oncologia Medica
English
Con Impact Factor ISI
Khanna, S., Thomas, A., Abate-Daga, D., Zhang, J., Morrow, B., Steinberg, S.m., et al. (2016). Malignant Mesothelioma Effusions Are Infiltrated by CD3+ T Cells Highly Expressing PD-L1 and the PD-L1+ Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti–PD-L1 Antibody Avelumab. JOURNAL OF THORACIC ONCOLOGY [10.1016/j.jtho.2016.07.033].
Khanna, S; Thomas, A; Abate Daga, D; Zhang, J; Morrow, B; Steinberg, S; Orlandi, A; Ferroni, P; Schlom, J; Guadagni, F; Hassan, R
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/164364
Citazioni
  • ???jsp.display-item.citation.pmc??? 48
  • Scopus 81
  • ???jsp.display-item.citation.isi??? 75
social impact